Your browser is no longer supported. Please, upgrade your browser.
RXRX [NASD]
Recursion Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-4.01 Insider Own5.30% Shs Outstand168.53M Perf Week-17.98%
Market Cap1.91B Forward P/E- EPS next Y-1.12 Insider Trans-4.35% Shs Float131.28M Perf Month-39.49%
Income-140.50M PEG- EPS next Q-0.31 Inst Own74.40% Short Float10.21% Perf Quarter-45.78%
Sales7.80M P/S245.24 EPS this Y-39.20% Inst Trans0.39% Short Ratio8.23 Perf Half Y-68.42%
Book/sh3.55 P/B2.88 EPS next Y5.90% ROA- Target Price32.67 Perf Year-
Cash/sh3.09 P/C3.30 EPS next 5Y24.10% ROE- 52W Range10.15 - 42.81 Perf YTD-40.34%
Dividend- P/FCF- EPS past 5Y- ROI44.10% 52W High-76.03% Beta-
Dividend %- Quick Ratio14.00 Sales past 5Y- Gross Margin- 52W Low1.08% ATR1.39
Employees218 Current Ratio14.00 Sales Q/Q147.20% Oper. Margin- RSI (14)25.08 Volatility13.72% 9.70%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.65 Prev Close10.22
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.63M Price10.26
Recom2.00 SMA20-28.24% SMA50-39.05% SMA200-57.80% Volume304,832 Change0.39%
Sep-21-21Initiated Berenberg Buy $37
May-11-21Initiated SVB Leerink Outperform $33
May-11-21Initiated KeyBanc Capital Markets Overweight $36
May-11-21Initiated JP Morgan Neutral $32
May-11-21Initiated Goldman Neutral $34
May-11-21Initiated BofA Securities Buy $31
Jan-12-22 08:36AM  
Dec-08-21 11:28AM  
Dec-07-21 07:55AM  
Dec-06-21 07:55AM  
Nov-30-21 07:55AM  
Nov-25-21 03:34PM  
Nov-10-21 04:39PM  
07:55AM  
Oct-11-21 09:18AM  
Oct-08-21 06:39AM  
Oct-07-21 07:55AM  
Sep-29-21 08:54AM  
08:47AM  
Sep-14-21 01:07AM  
Aug-13-21 07:55AM  
Jul-16-21 06:20AM  
Jul-13-21 07:55AM  
Jul-12-21 04:41PM  
Jul-01-21 08:54AM  
06:27AM  
Jun-23-21 08:53AM  
08:53AM  
Jun-15-21 08:54AM  
08:54AM  
May-25-21 08:25AM  
May-12-21 08:45AM  
Apr-27-21 06:33AM  
Apr-21-21 08:00AM  
Apr-16-21 05:32PM  
12:13AM  
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gibson ChristopherChief Executive OfficerJan 14Sale13.57254,0003,445,61223,470Jan 14 08:42 PM
Gibson ChristopherChief Executive OfficerJan 13Sale14.3387,0001,246,56623,470Jan 14 08:42 PM
Borgeson BlakeDirectorJan 04Sale18.039,625173,5287,651,146Jan 05 08:39 PM
Doyle RamonaChief Medical OfficerJan 03Option Exercise2.4740,32299,59540,322Jan 05 08:48 PM
Borgeson BlakeDirectorDec 21Sale18.759,625180,4787,660,216Dec 23 05:05 PM
Larson Tina MarriottPresident and COODec 16Sale18.742,50046,84847,500Dec 20 06:00 PM
Gibson ChristopherChief Executive OfficerDec 16Sale20.002004,00123,470Dec 20 05:59 PM
Gibson ChristopherChief Executive OfficerDec 13Sale20.021002,00223,470Dec 15 08:01 PM
Gibson ChristopherChief Executive OfficerDec 09Sale20.011,08621,73023,470Dec 10 09:42 PM
Gibson ChristopherChief Executive OfficerDec 08Option Exercise2.4728,64670,75628,646Dec 10 09:42 PM
Gibson ChristopherChief Executive OfficerDec 08Sale20.1510,664214,83223,470Dec 10 09:42 PM
Gibson ChristopherChief Executive OfficerDec 07Sale20.4816,667341,3328,201,216Dec 09 09:52 PM
Borgeson BlakeDirectorDec 07Sale20.329,625195,5337,669,841Dec 09 09:23 PM
Li Dean YDirectorDec 07Sale20.4815,900325,6301,315,000Dec 09 09:21 PM
Gibson ChristopherChief Executive OfficerDec 07Sale20.513,12564,101146,875Dec 09 09:52 PM
Li Dean YDirectorNov 19Sale20.2013,474272,226578,163Nov 19 05:40 PM
Larson Tina MarriottPresident and COONov 18Sale18.922,50047,30850,000Nov 22 08:23 PM
Borgeson BlakeDirectorNov 18Sale18.919,625182,0057,679,466Nov 22 08:20 PM
Li Dean YDirectorNov 17Sale20.045,626112,736591,637Nov 19 05:40 PM
Virani ShafiqueChief Corp. Dev. OfficerJun 02Option Exercise2.2245,045100,00063,045Jun 04 04:00 PM